Related references
Note: Only part of the references are listed.Protein Binding: Do We Ever Learn?
Markus A. Zeitlinger et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Preferential Emergence of Reduced Vancomycin Susceptibility in Health Care-Associated Methicillin-Resistant Staphylococcus aureus Isolates during Continuous-Infusion Vancomycin Therapy in an In Vitro Dynamic Model
Sheryl Zelenitsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Saturability of Granulocyte Kill of Pseudomonas aeruginosa in a Murine Model of Pneumonia
G. L. Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Optimization of Aminoglycoside Therapy
G. L. Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetic and Pharmacodynamic Analysis of Linezolid and a Hematologic Side Effect, Thrombocytopenia, in Japanese Patients
Tomohiro Sasaki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations
Jean-Marie Conil et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Antibiotic Dosing in Multiple Organ Dysfunction Syndrome
Marta Ulldemolins et al.
CHEST (2011)
Infections in Patients With Hematologic Neoplasms and Hematopoietic Stem Cell Transplantation: Neutropenia, Humoral, and Splenic Defects
Amar Safdar et al.
CLINICAL INFECTIOUS DISEASES (2011)
Vancomycin: We Can't Get There from Here
Nimish Patel et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2011)
Impact of Vancomycin Exposure on Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets
Ravina Kullar et al.
CLINICAL INFECTIOUS DISEASES (2011)
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
Marta Ulldemolins et al.
CLINICAL PHARMACOKINETICS (2011)
Pharmacodynamic Approaches to Optimizing Beta-Lactam Therapy
Jared L. Crandon et al.
CRITICAL CARE CLINICS (2011)
The Effect of Critical Illness on Drug Distribution
Daniel Gonzalez et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective
Johan W. Mouton et al.
DRUG RESISTANCE UPDATES (2011)
Pharmacodynamics of meropenem in critically ill patients with febrile neutropenia and bacteraemia
Sutep Jaruratanasirikul et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients
Jason A. Roberts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Molecular analysis of ciprofloxacin resistance and clonal relatedness of clinical Escherichia coli isolates from haematology patients receiving ciprofloxacin prophylaxis
Babette C. van Hees et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Antibiotic dosing in critically ill patients with acute kidney injury
Rachel F. Eyler et al.
NATURE REVIEWS NEPHROLOGY (2011)
High-Dose Continuous Infusion β-Lactam Antibiotics for the Treatment of Resistant Pseudomonas aeruginosa Infections in Immunocompromised Patients
Brad Moriyama et al.
ANNALS OF PHARMACOTHERAPY (2010)
Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection Model
G. L. Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The Combination of Meropenem and Levofloxacin Is Synergistic with Respect to both Pseudomonas aeruginosa Kill Rate and Resistance Suppression
Arnold Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis
Federico Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Diagnosis and Management of Infectious Complications in Critically Ill Patients with Cancer
Raghukumar Thirumala et al.
CRITICAL CARE CLINICS (2010)
In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy
Mickael Riou et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Reassessment of Recommended Imipenem Doses in Febrile Neutropenic Patients with Hematological Malignancies
F. Lamoth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Daptomycin Pharmacokinetics in Adult Oncology Patients with Neutropenic Fever
Joseph S. Bubalo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Vancomycin Dosage Optimization in Patients with Malignant Haematological Disease by Pharmacokinetic/Pharmacodynamic Analysis
Maria del Mar Fernández de Gatta et al.
CLINICAL PHARMACOKINETICS (2009)
Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?
Petros I. Rafailidis et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
New antimicrobial agents for the treatment of bacterial infections in cancer patients
Kenneth V. I. Rolston
HEMATOLOGICAL ONCOLOGY (2009)
Impact of Short-Course Quinolone Therapy on Susceptible and Resistant Populations of Staphylococcus aureus
G. L. Drusano et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Pharmacokinetics of vancomycin in adult cancer patients
Hadeel Al-Kofide et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2009)
Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia
Olivier Lortholary et al.
LANCET INFECTIOUS DISEASES (2008)
Tissue concentrations: do we ever learn?
Johan W. Mouton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses?
Ursula Theuretzbacher
CURRENT OPINION IN PHARMACOLOGY (2007)
Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally
George L. Drusano et al.
CLINICAL INFECTIOUS DISEASES (2007)
Back to the future: Using Aminoglycosides again and how to dose them optimally
George L. Drusano et al.
CLINICAL INFECTIOUS DISEASES (2007)
Optimizing drug exposure to minimize selection of antibiotic resistance
Sara K. Olofsson et al.
CLINICAL INFECTIOUS DISEASES (2007)
Pharmacokinetics and pharmacodynamics of levofloxacin in critically ill patients with ventilator-associated pneumonia
Ria Benko et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Pharmacokinetic/pharmaeodynamic factors influencing emergence of resistance to linezolid in an in vitro model
Lauren M. Boak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Piperacillin-tazobactam for Pseudomonas aeruginosa infection:: Clinical implications of an extended-infusion dosing strategy
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2007)
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore
Paul G. Ambrose et al.
CLINICAL INFECTIOUS DISEASES (2007)
Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection
Irma A. J. M. Bakker-Woudenberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective
Federico Pea et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis
Cornelia Buerger et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
EUCAST Technical Note on daptomycin
G Kahlmeter et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa
MD Maciá et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer
B Jaksic et al.
CLINICAL INFECTIOUS DISEASES (2006)
Evaluating ciprofloxacin dosing for Pseudomonas aeruginosa infection by using clinical outcome-based Monte Carlo simulations
S Zelenitsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis
MA Zeitlinger et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Antimicrobial therapy in critically ill patients - A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability
F Pea et al.
CLINICAL PHARMACOKINETICS (2005)
Pharmacokinetics and pharmacodynamics of meropenern in febrile neutropenic patients with bacteremia
RE Ariano et al.
ANNALS OF PHARMACOTHERAPY (2005)
Population pharmacokinetics of linezolid in patients treated in a compassionate-use program
AK Meagher et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme
CR Rayner et al.
CLINICAL PHARMACOKINETICS (2003)
Share Paper
